期刊文献+

一种肿瘤相关抗原在食管鳞状细胞癌中的鉴定与表达 被引量:3

Identification and Expression of A Tumor-associated Antigen in Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的寻找食管鳞状细胞癌的肿瘤相关抗原。方法采用二维凝胶电泳法分离食管鳞状细胞癌组织蛋白,转至PVDF膜上,与食管鳞状细胞癌患者和健康人血清分别杂交,进行Western blot分析,比较分析杂交后的差异蛋白,将差异蛋白经胰酶酶解后行质谱鉴定;采用免疫组织化学方法对鉴定的肿瘤相关抗原进行验证。结果食管鳞状细胞癌患者血清阳性杂交信号较多,其中相对分子质量为28 800的阳性率为60%(12/20),而对照血清阳性率为5%(1/20),两组相比差异有统计学意义(P<0.01)。经基质辅助激光解析/电离飞行时间质谱鉴定,该蛋白为磷酸甘油酸变位酶1(PGAM1)。免疫组织化学结果显示,PGAM1在食管鳞状细胞癌组织中的表达主要集中在细胞浆和细胞核,且明显高于癌旁正常组织。结论 PGAM1可能是食管鳞状细胞癌的肿瘤相关抗原。 Objective To search for novel tumor associated antigens (TAA) in esophageal squamous cell carcinoma (ESCC). Methods The proteins extracted from tissues of ESCC were separated by two dimen- sional polyacrylamide gel electrophoresis and transferred to PVDF membrane. Sera from ESCC patients and healthy individuals were used for primary antibodies for Western blot analysis. The differential spots were ex- cised for trypsin hydrolysis and the tryptic peptides were analyzed by matrix-assisted laser disorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The identified TAA of ESCC was validated by immunohis- tochemical staining (IHC). Results Sera from ESCC patients yielded multiple positive spots, and one 28 800 Da protein that exhibited positive reactivity with 60% (12/20) sera of ESCC patients and only 5% (1/20) sera of healthy controls (P 〈 0. 01 ). The 28 800 Da protein was identified as phosphoglycerate mutase 1 ( PGAM1 ) by MALDI-TOF-MS. Immunohistochemical analysis showed that PGAM1 was located in both cytoplasm and nucleus, and had a higher expression in cancer tissues. Conclusion PGAM1 maybe a candidate of ESCC.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2012年第3期244-248,共5页 Acta Academiae Medicinae Sinicae
关键词 肿瘤相关抗原 食管鳞状细胞癌 磷酸甘油酸变位酶1 表达 鉴定 tumor associated antigen esophageal squamous cell carcinoma phosphoglycerate mutase 1 expression identificaton
  • 相关文献

参考文献18

  • 1Vizcaino AP,Moreno V,Lambert R. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries,1973-1995[J].International Journal of Cancer,2002,(06):860-868.
  • 2Prasannan L,Misek DE,Hinderer R. Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma[J].Clinical Cancer Research,2000,(10):3949-3956.
  • 3高红军,赵晓航.SERPA技术及其在肿瘤相关抗原鉴定中的应用[J].医学综述,2010,16(18):2853-2855. 被引量:3
  • 4Fujita Y,Nakanishi T,Hiramatsu M. Proteomicsbased approach identifying autoantibody against peroxiredoxin Ⅵ as a novel serum marker in esophageal squamous cell carcinoma[J].Clinical Cancer Research,2006,(21):6415-6420.doi:10.1158/1078-0432.CCR-06-1315.
  • 5高红军,周兰萍,毛友生,王伟,乔媛媛,刘芳,蔡毅然,赵晓航.食管鳞癌肿瘤相关抗原磷酸甘油酸激酶1的鉴定[J].世界华人消化杂志,2008,16(17):1866-1872. 被引量:4
  • 6滕梁红,吕宁,赵晓航,薛丽燕,刘芳,林冬梅,王卉心,何祖根,谢永强,刘秀云.组织芯片技术检测食管癌前病变相关预警标志物[J].世界华人消化杂志,2005,13(1):6-9. 被引量:8
  • 7Qi Y,Chiu JF,Wang L. Comparative proteomic analysis of esophageal squarnous cell carcinoma[J].Proteomics,2005,(11):2960-2971.doi:10.1002/pmic.200401175.
  • 8Fothergill-Gilmore LA,Watson HC. The phosphoglycerate mutases[J].Advances in Enzymology and Related Areas of Molecular Biology,1989.227-313.
  • 9Scatena R,Bottoni P,Pontoglio A. Glycolytic enzyme inhibitors in cancer treatment[J].Expert Opinion on Investigational Drugs,2008,(10):1533-1545.doi:10.1517/13543784.17.10.1533.
  • 10Jones RG,Thompson CB. Tumor suppressors and cell metabolism:a recipe for cancer growth[J].Genes and Development,2009,(05):537-548.doi:10.1101/gad.1756509.

二级参考文献75

  • 1吴德,吴忠道,余新炳.磷酸甘油酸激酶的研究进展[J].中国热带医学,2005,5(2):385-387. 被引量:14
  • 2Shiku H,Takahashi T,Resnick LA,et al.Cell surface antigens of human malignant melanoma.Ⅲ.Recognition of autoantibodies with unusual characteristics[J] ,J Exp Med,1977,145(3):784-789.
  • 3Caron M,Choquet-Kastylevsky G,Joubert-Caron R.Cancer immunomics using autoantibody signatures for biomarker discovery[J].Mol Cell Proteomics,2007,6 (7):1115-1122.
  • 4Brichory FM,Misek DE,Yim AM,et al.Animmune response manifested by the common occurrence of annexins Ⅰ and Ⅱ autoantibodies and high circulating levels of IL-6 in lung cancer[J].Proc Natl Acad Sci U S A,2001,98(17):9824-9829.
  • 5Naora H,Yang YQ,Montz FJ,et al.A serologicallyidentified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells[J].Proc Natl Acad Sci U S A,2001,98(7):4060-4065.
  • 6Struss AK,Romeike BF,Munnia A,et al.PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme[J].Oncogene,2001,20(31):4107-4114.
  • 7Klade CS,Voss T,Krystek E,et al.Identification of tumor antigens in renal cell carcinoma by serological proteome analysis[J].Proteomics,2001,1 (7):890-898.
  • 8Prasannan L,Misek DE,Hindere r R,et al.Identification of betatubulin isoforms as tumor antigens in neuroblastoma[J].Clin Cancer Res,2000,6(10):3949-3956.
  • 9Kellner R,Lichtenfels R,Atkins D,et al.Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance[J].Proteomics,2002,2 (12):1743-1751.
  • 10Lichtenfels R,Kellner R,Atkins D,et al.Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses[J].Biochim Biophys Acta,2003,1646 (1/2):21-31.

共引文献8

同被引文献30

  • 1滕梁红,吕宁,赵晓航,薛丽燕,刘芳,林冬梅,王卉心,何祖根,谢永强,刘秀云.组织芯片技术检测食管癌前病变相关预警标志物[J].世界华人消化杂志,2005,13(1):6-9. 被引量:8
  • 2Grandjean M,Sermeus A,Branders S,et al.Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-e EF2 antibodies as potential cancer biomarkers[J].Plos One,2013(10):76508-76520.
  • 3Grandjean M,Dieu M,Raes M,et al.A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers[J].J Immunol Methods,2013(1):23-32.
  • 4Yang Z,Chevolot Y,Géhin T,et al.Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays:application to the sensitive and specific detection of tumor markers from breast cancer sera[J].Biosens Bioelectron,2013(1):385-392.
  • 5Kosuri P,Alegre-Cebollada J,Feng J,et al.Protein folding drives disulfide formation[J].Cell,2012(4):794-806.
  • 6Yang Z,Chevolot Y,Géhin T,et al.Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays:application to the sensitive and specific detection of tumor markers from breast cancer sera[J].Biosens Bioelectron,2013(1):385-392.
  • 7Matassa DS,Amoroso MR,Agliarulo I,et al.Translational control in the stress adaptive response of cancer cells:a novel role for the heat shock protein TRAP1[J].Cell Death Dis,2013(4):851.
  • 8Hallows WC,Yu W,Denu JM.Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation[J].J Biol Chem,2012(6):3850-3858.
  • 9Ren F,Wu H,Lei Y,et al.Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma[J].Mol Cancer,2010(81):1-17.
  • 10Buffa FM,Harris AL,West CM,et al.Large meta-analysis of multiple cancers reveals a common,compact and highly prognostic hypoxia metagene[J].Br J Cancer,2010(2):428-435.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部